Skip to content

Timing of Active Void Trials After Urogynecologic Procedures

Timing of Active Void Trials After Urogynecologic Procedures

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05885958
Enrollment
231
Registered
2023-06-02
Start date
2023-07-03
Completion date
2025-06-05
Last updated
2025-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Care, Urinary Catheters, Urogynecology

Brief summary

The goal of this clinical trial is to learn about active void trial pass rates in patients undergoing urogynecologic surgery. The main question it aims to answer is the comparison in pass rate during active void trial between women who are given 30 minutes versus 60 minutes to void following urogynecologic surgery. Patient will be randomized to two arms prior to scheduled surgery. During the active void trial, women will be allotted up to 30 minutes or up to 60 minutes to void depending on respective randomization.

Interventions

OTHERTime

Patients will be given up to 30 minutes to void.

Sponsors

University of South Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women undergoing a urogynecologic surgery at Tampa General Hospital and who are seen preoperatively at the University of South Florid Urogynecology clinic * Women undergoing a urogynecologic surgery where a postoperative active void trial is indicated * Planned for same day surgery * Women able to consent for themselves * Speak English and/or Spanish as preferred language

Exclusion criteria

* Imprisoned patients * Females under the age of 18 years old * Women who are unable or unwilling to consent to participation * Women who are planning to stay inpatient overnight * Women with history of urinary retention or neurogenic bladder * Women undergoing procedure that is not standard of care to perform a void trial (includes sacral neuromodulation, botox to the pelvic floor, cystoscopy with hydrodistension, urethral bulking, etc)

Design outcomes

Primary

MeasureTime frameDescription
Pass Rate60 minutesto compare the active void trial pass rate between arms

Secondary

MeasureTime frameDescription
Time in PACU6 hoursto compare overall time spent in the PACU between arms
Pass Rate After Failing60 minutesto assess the overall pass rate of active void trial after failed first attempt
UTI2 weeksto assess rate of urinary tract infection after surgery
Surgical Procedures Performed Prior to Active Void Trial2 yearsto compare types of surgery women are having with the rate of void trial passing

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026